Cite
Lucasti C, Jasovich A, Umeh O, et al. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clin Ther. 2008;30(5):868-83doi: 10.1016/j.clinthera.2008.04.019.
Lucasti, C., Jasovich, A., Umeh, O., Jiang, J., Kaniga, K., & Friedland, I. (2008). Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clinical therapeutics, 30(5), 868-83. https://doi.org/10.1016/j.clinthera.2008.04.019
Lucasti, Christopher, et al. "Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study." Clinical therapeutics vol. 30,5 (2008): 868-83. doi: https://doi.org/10.1016/j.clinthera.2008.04.019
Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clin Ther. 2008 May;30(5):868-83. doi: 10.1016/j.clinthera.2008.04.019. PMID: 18555934.
Copy
Download .nbib